Cel-Sci
CVM
#9935
Rank
โ‚ฌ31.74 M
Marketcap
3,97ย โ‚ฌ
Share price
5.41%
Change (1 day)
-80.33%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -โ‚ฌ22.54 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ22.55 Million, an increase over its 2023 earnings that were of -โ‚ฌ25.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ22.54 Million-0.05%
2024 -โ‚ฌ22.55 Million-12.41%
2023 -โ‚ฌ25.74 Million-12.87%
2022 -โ‚ฌ29.55 Million-3.42%
2021 -โ‚ฌ30.59 Million13.44%
2020 -โ‚ฌ26.97 Million11.28%
2019 -โ‚ฌ24.23 Million179.81%
2018 -โ‚ฌ8.66 Million-48.72%
2017 -โ‚ฌ16.89 Million-16.23%
2016 -โ‚ฌ20.16 Million-23.63%
2015 -โ‚ฌ26.4 Million-5.47%
2014 -โ‚ฌ27.93 Million198.49%
2013 -โ‚ฌ9.36 Million
2010 -โ‚ฌ10.92 Million
2004 -โ‚ฌ3.7 Million12.38%
2003 -โ‚ฌ3.29 Million-16.59%
2002 -โ‚ฌ3.94 Million-59.28%
2001 -โ‚ฌ9.67 Million23.17%
2000 -โ‚ฌ7.85 Million20.12%
1999 -โ‚ฌ6.54 Million13.24%
1998 -โ‚ฌ5.78 Million-20%
1997 -โ‚ฌ7.22 Million46.55%
1996 -โ‚ฌ4.93 Million34.88%
1995 -โ‚ฌ3.65 Million2.38%
1994 -โ‚ฌ3.57 Million68%
1993 -โ‚ฌ2.13 Million78.57%
1992 -โ‚ฌ1.19 Million180%
1991 -โ‚ฌ0.43 Million25%
1990 -โ‚ฌ0.34 Million-0%
1989 -โ‚ฌ0.34 Million-71.43%
1988 -โ‚ฌ1.19 Million-0%
1987 -โ‚ฌ1.19 Million-46.15%
1986 -โ‚ฌ2.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-โ‚ฌ27.63 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.62 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ6.99 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚ฌ0.12 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.50 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ27.49 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.06 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA